Related Experiment Video
Updated: Aug 16, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Colorectal cancer adjuvant treatment in elderly patients
Lara Maria Pasetto1, Elena Rossi, Antonio Jirillo
1Divisione di Oncologia Medica-Direzione, Via Gattamelata 64, Azienda Ospedale-Università, 35128 Padova, Italy. laramary@libero.it
Abstract:
Colorectal adenocarcinoma ranks second as a cause of death due to cancer in the Western world. In Europe, 40% of patients with this disease is over 70 years old and only 52% of them with positive nodes usually receive an adjuvant chemotherapy. Despite early reports to the contrary, these patients tolerate cancer treatment and surgical resections as well as their younger counterparts but as a result of exclusion criteria, those receiving an adjuvant therapy are very few. This paper examines the factors pertinent to the small number of clinical trials designed for adjuvant colorectal cancer in the elderly.
Related Concept Videos
Drug Dosing: Geriatric Patients
Drugs for Treatment of Ulcerative Colitis in IBD
Pharmacodynamics in Geriatric Patients: Effects of Age
Drugs for Treatment of Constipation-Predominant IBS
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion